dr. diefenbach on ipilimumab/brentuximab vedotin in patients with rr hodgkin lymphoma
Published 9 years ago • 327 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
3:53
e4412 update: ipi-nivo-brentuximab for r/r hodgkin lymphoma
-
5:14
brentuximab vedotin in hodgkin lymphoma
-
1:23
ipilimumab, nivolumab & brentuximab vedotin for r/r hodgkin lymphoma
-
6:45
brentuximab vedotin with nivolumab ± ipilimumab in r/r hl: outcomes with and without autosct
-
2:43
hodgkin lymphoma: using brentuximab vedotin frontline
-
1:08
nivolumab and brentuximab vedotin with or without bendamustine for r/r hodgkin lymphoma
-
0:53
alex herrera on nivolumab/brentuximab vedotin combination for patients with hodgkin lymphoma
-
1:52
dr. diefenbach on polatuzumab vedotin plus obinutuzumab and lenalidomide in fl
-
1:27
treatment options for patients with hodgkin lymphoma who progress after brentuximab vedotin
-
3:34
evolving role of brentuximab vedotin in hodgkin lymphoma
-
2:23
real-world data on brentuximab vedotin with chemotherapy in hodgkin lymphoma
-
1:52
dr. diehl discusses brentuximab vedotin
-
1:02
dr. hamdan on the potential use of brentuximab vedotin/nivolumab in hodgkin lymphoma
-
4:07
utilization of brentuximab vedotin in hodgkin lymphoma
-
1:42
brentuximab vedotin after autosct in pediatric patients with r/r hodgkin lymphoma
-
0:44
dr. hamlin on brentuximab vedotin pharmacology
-
6:57
brentuximab vedotin in cd30-positive lymphoma
-
3:47
brentuximab vedotin plus chemotherapy prior to asct in r/r hodgkin lymphoma
-
0:55
dr. lacasce on treating relapsed/ refractory hodgkin lymphoma with brentuximab vedotin combo